EVEROLIMUS AND SORAFENIB FOR RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION

被引：0
|
作者：
De Simone, Paolo [1 ]
Pezzati, Daniele [1 ]
Lai, Quirino [1 ]
Ghinolfi, Davide [1 ]
Coletti, Laura [1 ]
Precisi, Arianna [1 ]
Leonardi, Giulia [1 ]
Carrai, Paola [1 ]
Filipponi, Franco [1 ]
机构：
[1] Univ Pisa, Med Sch Hosp, I-56100 Pisa, Italy
来源：
TRANSPLANT INTERNATIONAL | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：293 / 293
页数：1
相关论文
共 50 条
  • [1] Everolimus plus Sorafenib as a treatment option for hepatocellular carcinoma recurrence after liver transplantation
    Saliba, Faouzi
    Nitta, Hidetoshi
    Younes, Aline
    Karam, Vincent H.
    Sobesky, Rodolphe
    Vibert, Eric
    Coilly, Audrey
    Antonini, Theresa
    Cherqui, Daniel
    Adam, Rene
    Samuel, Didier
    HEPATOLOGY, 2017, 66 : 901A - 902A
  • [2] EVEROLIMUS PLUS SORAFENIB AS A TREATMENT OPTION FOR HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
    Saliba, F.
    Younes, A.
    Nitta, H.
    Karam, V.
    Sobesky, R.
    Vibert, E.
    Coilly, A.
    Antonini, T.
    Cherqui, D.
    Baba, H.
    Adam, R.
    Samuel, D.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 17 - 17
  • [3] Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation
    Weinmann, Arndt
    Niederle, Ina Maria
    Koch, Sandra
    Hoppe-Lotichius, Maria
    Heise, Michael
    Dueber, Christoph
    Schuchmann, Marcus
    Otto, Gerd
    Galle, Peter Robert
    Woerns, Marcus-Alexander
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (05) : 432 - 437
  • [4] Efficacy and Safety of Combination Therapy With Everolimus and Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation
    De Simone, P.
    Crocetti, L.
    Pezzati, D.
    Bargellini, I.
    Ghinolfi, D.
    Carrai, P.
    Leonardi, G.
    Della Pina, C.
    Cioni, D.
    Pollina, L.
    Campani, D.
    Bartolozzi, C.
    Lencioni, R.
    Filipponi, F.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (01) : 241 - 244
  • [5] Effect of everolimus on hepatocellular carcinoma recurrence after liver transplantation
    Joo, D. J.
    Lee, J. J.
    Kim, D. G.
    Lee, J. G.
    Lee, J.
    Kim, S. H.
    Han, D. H.
    Lee, H. S.
    Ju, M. K.
    Choi, G. H.
    Choi, J. S.
    Kim, M. S.
    Kim, S., I
    TRANSPLANTATION, 2019, 103 (08) : 54 - 55
  • [6] Everolimus mitigates the risk of hepatocellular carcinoma recurrence after liver transplantation
    De Simone, Paolo
    Precisi, Arianna
    Lai, Quirino
    Ducci, Juri
    Campani, Daniela
    Marchetti, Piero
    Gitto, Stefano
    JOURNAL OF HEPATOLOGY, 2024, 80 : S456 - S456
  • [7] Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation
    De Simone, Paolo
    Precisi, Arianna
    Lai, Quirino
    Ducci, Juri
    Campani, Daniela
    Marchetti, Piero
    Gitto, Stefano
    CANCERS, 2024, 16 (07)
  • [8] Lenvatinib versus sorafenib for recurrence of hepatocellular carcinoma after liver transplantation
    Perera, S.
    Magyar, C. T. J.
    Rajendran, L.
    Li, Z.
    Almugbel, F. A.
    Feng, S.
    Choi, W. J.
    Aceituno, L.
    Selzner, N.
    Jaeckel, E.
    Falla-Rad, N.
    Knox, J. J.
    Chen, E. X.
    O'Kane, G. M.
    Sapisochin, G.
    ANNALS OF ONCOLOGY, 2024, 35 : S82 - S83
  • [9] Sorafenib Reduced Recurrence of Large Hepatocellular Carcinoma after Liver Transplantation
    Asham, Emad
    Boktour, Maha
    Mcfaden, Robert
    Monsour, Howard
    Gaber, Osama
    Ghobrial, R. Mark
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 88 - 88
  • [10] Impact of Early Initiated Everolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
    Rodriguez-Peralvarez, Manuel
    Guerrero, Marta
    Barrera, Lydia
    Ferrin, Gustavo
    Alamo, Jose M.
    Ayllon, Maria D.
    Suarez Artacho, Gonzalo
    Montero, Jose L.
    Briceno, Javier
    Bernal, Carmen
    Padillo, Javier
    Marin-Gomez, Luis M.
    Pascasio, Juan M.
    Poyato, Antonio
    Gomez-Bravo, Miguel A.
    De la Mata, Manuel
    TRANSPLANTATION, 2018, 102 (12) : 2056 - 2064
12345